Core Viewpoint - Aishide (002416.SZ) reported a decline in both revenue and net profit for the third quarter of 2025, indicating challenges in its financial performance [1] Financial Performance - The company's operating revenue for the third quarter was 14.005 billion yuan, a year-on-year decrease of 24.75% [1] - The net profit attributable to shareholders was 116 million yuan, down 10.73% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 108 million yuan, reflecting a year-on-year decline of 15.44% [1]

Group 1 - The core viewpoint of the news is that Aishide (002416) is experiencing a strategic transformation focusing on high-value-added businesses, which has led to improved operational quality and financial performance despite short-term revenue and profit pressures [1][3] - In the first three quarters of 2025, Aishide achieved a revenue of 39.375 billion yuan and a net profit attributable to shareholders of 337 million yuan, indicating a proactive approach to restructuring low-margin segments [1] - The company's cash flow from operating activities reached 2.7 billion yuan, with a year-on-year increase of 129%, reflecting enhanced sales collection efficiency and cost control [1] Group 2 - Aishide has established a 500 million yuan "Aishide Smart City Fund" in collaboration with a state-owned investment platform, focusing on AI, smart terminals, and robotics, which aligns with government policy support [2] - The fund has made two significant investments in companies specializing in robotics and flexible tactile sensors, showcasing Aishide's unique competitive advantage through its extensive distribution network [2] - The company’s distribution network covers over 100,000 mobile phone stores nationwide, providing essential market access and support for invested companies, thus creating a "technology + channel" synergy [2] Group 3 - The combination of policy benefits and Aishide's strengths is driving the construction of a "industry + capital + channel" growth model, with the current 500 million yuan fund seen as just the starting point [3] - Aishide is expected to leverage its channel resources and industry insights to evolve the fund from a mere investment tool to a platform for industry integration under policy guidance [3] - The company is well-positioned to expand its industrial layout in response to the recovery of the consumer electronics industry and the cultivation of new productive forces, indicating significant future growth potential [3]

Core Viewpoint - Aishide (002416) reported a significant decline in both revenue and net profit for the third quarter of 2025, indicating challenges in market share and business structure optimization [1] Financial Performance - The company's third-quarter revenue was 14.005 billion yuan, a year-on-year decrease of 24.75% [1] - Net profit for the third quarter was 116 million yuan, down 10.73% year-on-year [1] - For the first three quarters, total revenue reached 39.375 billion yuan, reflecting a year-on-year decline of 31.47% [1] - Net profit for the first three quarters was 337 million yuan, a decrease of 35.78% compared to the previous year [1] Market Position - The company's brand market share has declined during the reporting period [1] - Aishide is undergoing optimization and adjustment of its business structure, which has contributed to the decrease in sales scale [1]

Group 1: Company Performance - Aishide reported a revenue of approximately 39.375 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 31.47% [1] - The net profit attributable to shareholders of the listed company was approximately 337 million yuan, down 35.78% year-on-year [1] - The basic earnings per share were 0.2721 yuan, reflecting a decrease of 35.76% compared to the previous year [1] Group 2: Market Context - As of the report, Aishide's market capitalization stood at 15.9 billion yuan [2] - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion US dollars this year [2] - There is a contrast in the biopharmaceutical market, where the secondary market is thriving while the primary market is facing challenges in fundraising [2]

证券代码：002416 证券简称：爱施德 公告编号：2025-055 深圳市爱施德股份有限公司 关于续聘公司2025年度审计机构的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 本次续聘中审众环会计师事务所（特殊普通合伙）符合财政部、国务院国资委、 证监会印发的《国有企业、上市公司选聘会计师事务所管理办法》（财会〔2023〕4 号）的规定。 深圳市爱施德股份有限公司（以下简称"公司"）于 2025 年 10 月 24 日召开第六 届董事会第二十二次（临时）会议审议通过了《关于续聘公司 2025 年度审计机构的议 案》，同意续聘中审众环会计师事务所（特殊普通合伙）（以下简称"中审众环"） 为公司 2025 年度审计机构，该议案尚需提交公司股东会审议。现将具体内容公告如下： 一、拟续聘会计师事务所事项的情况说明 中审众环始创于 1987 年，是全国首批取得国家批准具有从事证券、期货相关业务 资格及金融业务审计资格的大型会计师事务所之一，持有财政部及中国证监会联合颁 发的会计师事务所证券、期货相关业务审计从业资格，本所具备股份有限公司发行股 份、债 ...

证券代码：002416 证券简称：爱施德 公告编号：2025-053 二、审议通过了《关于续聘公司 2025 年度审计机构的议案》 第六届董事会第二十二次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳市爱施德股份有限公司（以下简称"公司"）第六届董事会第二十二次（临 时）会议通知于 2025 年 10 月 21 日以电子邮件及通讯方式送达全体董事，以现场、通 讯方式于 2025 年 10 月 24 日下午在公司深圳总部 18 层 A 会议室召开了本次会议。本 次会议应出席董事 7 名，实际出席董事 7 名，其中董事黄文辉先生、周友盟女士、独 立董事林斌先生出席现场会议，董事黄绍武先生、喻子达先生、独立董事吕良彪先生、 葛俊先生以通讯方式参会并进行表决。公司部分高级管理人员列席了本次会议。本次 会议的出席人数、召集、召开程序和议事内容均符合《中华人民共和国公司法》和《公 司章程》的规定。 本次会议由董事长黄文辉先生召集并主持。经与会董事投票表决，做出如下决议： 一、审议通过了《2025 年第三季度报告》 表决结果：同意 7 票，反对 ...

Financial Performance - The company's revenue for Q3 2025 was ¥14,005,040,889.85, a decrease of 24.75% compared to the same period last year[4]. - Net profit attributable to shareholders was ¥115,605,390.94, down 10.73% year-on-year, while the net profit excluding non-recurring items was ¥107,529,270.25, a decline of 15.44%[4]. - The company experienced a 31.47% decline in total revenue for the first nine months of 2025 compared to the same period in 2024, primarily due to a decrease in market share[8]. - Total operating revenue for the period was CNY 39,375,350,355.54, a decrease from CNY 57,458,388,237.18 in the previous period, representing a decline of approximately 31.4%[22]. - Operating profit for the period was CNY 573,913,999.80, compared to CNY 809,307,663.29 in the previous period, reflecting a decrease of approximately 29.1%[22]. - Net profit for the period after tax expenses was CNY 396,945,271.09, down from CNY 575,300,186.67, a decline of around 30.9%[22]. - The net profit for the current period is approximately ¥396.95 million, a decrease from ¥575.30 million in the previous period, representing a decline of about 30.96%[23]. - The net profit attributable to the parent company's shareholders is approximately ¥337.16 million, down from ¥524.99 million, reflecting a decrease of around 35.73%[23]. - The total comprehensive income for the current period is approximately ¥383.78 million, compared to ¥572.69 million in the previous period, indicating a decline of about 33.05%[23]. - The basic and diluted earnings per share for the current period are both ¥0.2721, down from ¥0.4236 in the previous period, a decrease of approximately 35.83%[23]. Assets and Liabilities - The total assets at the end of the reporting period were ¥12,813,096,864.70, reflecting a 7.43% increase from the end of the previous year[4]. - Total assets increased to CNY 12,813,096,864.70 from CNY 11,927,083,821.06, reflecting a growth of approximately 7.4%[21]. - Total liabilities rose to CNY 6,685,737,405.80 from CNY 5,432,882,053.85, indicating an increase of about 23.0%[21]. - The company's equity attributable to shareholders decreased to CNY 5,823,438,656.49 from CNY 6,117,324,142.79, a decline of approximately 4.8%[21]. - The company's total liabilities increased, with accounts payable rising by 149.51% to ¥1,629,419,593.86, attributed to increased purchases from suppliers[8]. Cash Flow - The company reported a significant increase in cash flow from operating activities, amounting to ¥2,701,399,586.98, which is a 129.21% increase year-to-date[4]. - Cash flow from operating activities generated a net cash inflow of approximately ¥2.70 billion, an increase from ¥1.18 billion in the previous period, representing a growth of about 129.00%[24]. - Cash inflow from investment activities totaled approximately ¥1.75 billion, down from ¥2.07 billion, indicating a decrease of about 15.16%[25]. - Cash flow from financing activities resulted in a net outflow of approximately ¥793.64 million, compared to a net inflow of ¥504.95 million in the previous period, reflecting a significant change[26]. - The ending balance of cash and cash equivalents is approximately ¥3.75 billion, a decrease from ¥3.95 billion in the previous period, representing a decline of about 4.94%[26]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 76,159[11]. - Shenzhen Shenzhou Tong Investment Group Co., Ltd. holds 39.50% of shares, totaling 489,464,303 shares[11]. - The second-largest shareholder, Ganjian New District Global Star Investment Management Co., Ltd., holds 4.36% of shares, totaling 54,000,000 shares[11]. Investments and Partnerships - The company has established a partnership with Shenzhen Smart City Investment Private Fund Management Co., Ltd. to create the Shenzhen Aishide Smart City Industry Investment M&A Partnership, with a total subscribed capital of RMB 500 million[14]. - The first phase of the Aishide Smart City Fund has completed a capital contribution of RMB 51.918367 million[15]. - The company participated in a new round of financing for Hangzhou Yundong Technology Co., Ltd. in July 2025[15]. - The company plans to acquire limited partner shares in a controlling enterprise to optimize its external investment structure[16]. - The company holds a 25.5539% stake in Shenzhen Xingmeng Information Technology Partnership through its subsidiary[16]. Other Financial Metrics - The company's financial expenses decreased by 41.30% to ¥50,008,909.46, resulting from optimized financing structures[9]. - The company’s cash flow from financing activities showed a significant decline of 257.17%, indicating reduced financing needs[9]. - Research and development expenses were CNY 15,939,592.27, down from CNY 19,543,705.85, a decrease of about 18.0%[22]. - The company reported a decrease in other comprehensive income, with a tax effect of approximately -¥13.16 million compared to -¥2.61 million in the previous period[23]. - The company has not undergone an audit for the third quarter financial report[27].

Core Insights - The professional chain sector experienced a decline of 1.27% on October 24, with Tianyin Holdings leading the drop [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Sector Performance - The professional chain sector saw mixed performance among individual stocks, with 博士眼镜 (Doctor Glasses) rising by 0.85% to a closing price of 29.77, while 天音控股 (Tianyin Holdings) fell by 2.88% to 10.13 [1] - The trading volume for the sector was significant, with 孩子王 (Kids King) recording a volume of 334,700 shares and a transaction value of 365 million yuan [1] Capital Flow - The professional chain sector experienced a net outflow of 41.16 million yuan from institutional investors, while retail investors saw a net inflow of 39.68 million yuan [1] - Individual stock capital flows showed that 博士眼镜 had a net inflow of over 9.58 million yuan from institutional investors, while 天音控股 faced a net outflow of 30.03 million yuan [2]

Core Insights - The professional chain sector experienced a rise of 0.81% on October 23, with Aishide leading the gains [1] - The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index closed at 13025.45, also up 0.22% [1] Stock Performance - Aishide (002416) closed at 13.15, with an increase of 1.70% and a trading volume of 917,800 shares, amounting to 1.197 billion yuan [1] - Tianyin Holdings (000829) closed at 10.43, up 1.16%, with a trading volume of 896,400 shares, totaling 958 million yuan [1] - Aige Shih (603214) closed at 18.73, up 0.70%, with a trading volume of 36,100 shares, amounting to 67.4184 million yuan [1] - Huazhi Wine (300755) closed at 18.78, up 0.64%, with a trading volume of 25,900 shares, totaling 48.0761 million yuan [1] - Kids Wang (301078) closed at 10.89, up 0.28%, with a trading volume of 250,700 shares, amounting to 270 million yuan [1] - Jifeng Technology (300022) closed at 8.48, down 0.24%, with a trading volume of 106,500 shares, totaling 89.7187 million yuan [1] - Doctor Glasses (300622) closed at 29.52, down 0.24%, with a trading volume of 40,400 shares, amounting to 118 million yuan [1] Capital Flow - The professional chain sector saw a net inflow of 20.8314 million yuan from main funds, while speculative funds had a net inflow of 52.7208 million yuan, and retail investors experienced a net outflow of 73.5522 million yuan [1] - Aishide (002416) had a main fund net inflow of 73.5037 million yuan, representing 6.14% of total inflow, while retail investors had a net outflow of 111 million yuan, or -9.27% [2] - Aige Shih (603214) recorded a main fund net inflow of 4.4964 million yuan (6.67%) and a retail net outflow of 6.1125 million yuan (-9.07%) [2] - Tianyin Holdings (000829) experienced a main fund net outflow of 4.6970 million yuan (-0.49%) and a retail net outflow of 11.5315 million yuan (-1.20%) [2] - Huazhi Wine (300755) had a main fund net outflow of 5.1278 million yuan (-10.67%) but a retail net inflow of 539.25 million yuan (11.22%) [2] - Jifeng Technology (300022) saw a main fund net outflow of 10.1560 million yuan (-11.32%) and a retail net inflow of 446.55 million yuan (4.98%) [2] - Doctor Glasses (300622) had a main fund net outflow of 11.3808 million yuan (-9.62%) but a retail net inflow of 1.5469 million yuan (13.07%) [2] - Kids Wang (301078) experienced a main fund net outflow of 25.8071 million yuan (-9.54%) and a retail net inflow of 29.6542 million yuan (10.97%) [2]

Core Insights - The professional chain sector increased by 0.64% on October 22, with Tianyin Holdings leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - Tianyin Holdings (000829) closed at 10.31, up 5.31% with a trading volume of 294,400 shares and a transaction value of 296 million [1] - Aishide (002416) closed at 12.93, up 2.54% with a trading volume of 426,300 shares and a transaction value of 540 million [1] - Aizhi Room (603214) remained unchanged at 18.60 with a trading volume of 27,600 shares and a transaction value of 51 million [1] - Doctor Glasses (300622) closed at 29.59, down 1.00% with a trading volume of 39,600 shares and a transaction value of 117 million [1] - Jifeng Technology (300022) closed at 8.50, down 1.16% with a trading volume of 91,300 shares and a transaction value of 77.6 million [1] - Huazhi Wine (300755) closed at 18.66, down 1.27% with a trading volume of 27,100 shares and a transaction value of 50.7 million [1] - Kids Wang (301078) closed at 10.86, down 2.51% with a trading volume of 330,000 shares and a transaction value of 362 million [1] Capital Flow - The professional chain sector experienced a net outflow of 41.61 million from institutional investors, while retail investors saw a net inflow of 55.54 million [1] - Tianyin Holdings had a net inflow of 35.36 million from institutional investors, while retail investors had a net outflow of 17.06 million [2] - Aishide saw a net inflow of 2.14 million from institutional investors, with retail investors also experiencing a net outflow of 1.29 million [2] - Doctor Glasses had a significant net outflow of 16.90 million from institutional investors, but retail investors had a net inflow of 22.07 million [2] - Kids Wang faced a net outflow of 59.22 million from institutional investors, while retail investors had a net inflow of 50.26 million [2]